Faculdade de Medicina da Universidade do Porto, Porto, Portugal.
Department of Gynecology-Obstetrics and Pediatrics, Faculty of Medicine, University of Porto, Porto, Portugal.
J Perinat Med. 2023 Oct 20;52(1):90-95. doi: 10.1515/jpm-2023-0156. Print 2024 Jan 29.
This study aims to evaluate if low levels of serum maternal pregnancy associated plasma protein-A (PAPP-A) during the first trimester are related to increased umbilical artery pulsatility index (UA PI) later in pregnancy, in cases of estimated fetal weight between the 3rd and 10th percentiles, in order to establish PAPP-A as a predictor of this particular cases of fetal growth restriction (FGR).
An observational, retrospective cohort study, conducted at a tertiary University Hospital located in Oporto, Portugal. Pregnant women who did the first trimester combined screening, between May 2013 and June 2020 and gave birth in the same hospital, with an estimated fetal weight (EFW) between the 3rd and 10th percentiles were included. The primary outcome is the difference in increased UA PI prevalence between two groups: PAPP-A<0.45 MoM and PAPP-A≥0.45 MoM. As secondary outcomes were evaluated differences in neonatal weight, gestational age at delivery, cesarean delivery, neonatal intensive care unit hospitalization, 5-min Apgar score below 7 and live birth rate between the same two groups.
We included 664 pregnancies: 110 cases of PAPP-A<0.45 MoM and 554 cases with PAPP-A≥0.45 MoM. Increased UA PI prevalence, which was the primary outcome of this study, was significantly different between the two groups (p=0.005), as the PAPP-A<0.45 MoM group presents a higher prevalence (12.7 %) when compared to the PAPP-A≥0.45 MoM group (5.4 %). The secondary outcome cesarean delivery rate was significantly different between the groups (p=0.014), as the PAPP-A<0.45 MoM group presents a higher prevalence (42.7 %) than the PAPP-A≥0.45 MoM group (30.1 %). No other secondary outcomes showed differences between the two groups.
There is an association of low serum maternal PAPP-A (<0.45 MoM) during the first trimester and increased UA PI (>95th percentile) later in pregnancy, in cases of EFW between the 3rd and 10th percentiles. However, this association is not strong enough alone for low PAPP-A to be a reliable predictor of increased UA PI in this population.
本研究旨在评估在估计胎儿体重处于第 3 至 10 百分位的情况下,妊娠早期母体血清妊娠相关血浆蛋白 A(PAPP-A)水平较低是否与妊娠后期脐动脉搏动指数(UA PI)升高有关,以确定 PAPP-A 是否可预测此类胎儿生长受限(FGR)病例。
这是一项在葡萄牙波尔图的一家三级大学医院进行的观察性、回顾性队列研究。纳入 2013 年 5 月至 2020 年 6 月期间进行了早孕期联合筛查并在同一家医院分娩的孕妇,估计胎儿体重(EFW)处于第 3 至 10 百分位。主要结局是两组间 UA PI 升高的患病率差异:PAPP-A<0.45 MoM 和 PAPP-A≥0.45 MoM。次要结局为新生儿体重、分娩时的胎龄、剖宫产、新生儿重症监护病房住院、5 分钟 Apgar 评分<7 分和活产率的差异。
我们纳入了 664 例妊娠:PAPP-A<0.45 MoM 组 110 例,PAPP-A≥0.45 MoM 组 554 例。主要结局(研究中的 UA PI 升高患病率)在两组间差异有统计学意义(p=0.005),PAPP-A<0.45 MoM 组(12.7%)高于 PAPP-A≥0.45 MoM 组(5.4%)。次要结局剖宫产率在两组间差异有统计学意义(p=0.014),PAPP-A<0.45 MoM 组(42.7%)高于 PAPP-A≥0.45 MoM 组(30.1%)。其他次要结局在两组间无差异。
在 EFW 处于第 3 至 10 百分位的情况下,妊娠早期母体血清 PAPP-A(<0.45 MoM)水平较低与妊娠后期 UA PI(>95 百分位)升高有关。然而,这种关联本身还不够强,不足以使低 PAPP-A 成为该人群中 UA PI 升高的可靠预测指标。